Publication details
Je kombinace inhibitorů ACE a blokátorů receptorů pro angiotenzin II v léčbě kardiovaskulárních onemocnění indikovaná?
| Title in English | Is the combination therapy with ACE inhibitors and angiotensin II type 1 receptor blockers indicated in the treatment of cardiovascular diseases? |
|---|---|
| Authors | |
| Year of publication | 2009 |
| Type | Article in Periodical |
| Magazine / Source | časopis Remedia |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | angiotensin-converting enzyme inhibitors; angiotensin II type 1 receptor blockers; hypertension; heart failure; myocardial infarction; coronary artery disease |
| Description | The article deals with the pathophysiological basis for the combination therapy with ACE inhibitors and angiotensin II type 1 receptor blockers (sartans) in the treatment of hypertension, heart failure, post myocardial infarction condition and in secondary prevention of CAD. In particular, risks posed by this combination therapy that influences angiotensin II formation or action are discussed in the light of clinical trials and clinical practice. |
| Related projects: |